
    
      Specific Aims of Study

        1. To determine the safety profile of an intravenous omega-3 fat emulsion (Omegavenâ„¢)

        2. To determine if established PN associated liver disease can be reversed or its
           progression halted by using a parenteral fat emulsion prepared from fish oil as measured
           by normalization of serum levels of hepatic enzymes and bilirubin.
    
  